Jump to main content
Jump to site search


A successful search for new, efficient, and silver-free manufacturing processes for key platinum(ii) intermediates applied in antibody–drug conjugate (ADC) production

Author affiliations

Abstract

A silver-free amination procedure, here called “complexation”, was developed to obtain a class of Pt(II) complexes bearing a payload (such as a diagnostic or a therapeutic moiety). These complexes are crucial intermediates for the efficient development and production of antibody–drug conjugates (ADCs) based on a novel Pt(II)-based linker technology. We termed this metal–organic linker, [ethylenediamineplatinum(II)]2+, “Lx”®. The present, newly developed procedure is a greener alternative for the classically applied activation reaction of Pt-halido complexes with silver salts, followed by amination. The crucial finding is that the leaving ligand of the classical process, chloride, can now be replaced by its higher homologue iodide. This not only decisively improved the manufacturing process of the intermediate, but also was found to be key to a more efficient conjugation procedure, i.e. a subsequent step in which this intermediate is coupled to an antibody. The new process allowed upscaling to be readily realized and the desired intermediate was successfully manufactured on a multigram scale. The obtained Ag-free procedure can be generalized and has a great potential to be applied for other Pt(II) complexes of high importance, such as anti-cancer therapeutics.

Graphical abstract: A successful search for new, efficient, and silver-free manufacturing processes for key platinum(ii) intermediates applied in antibody–drug conjugate (ADC) production

Back to tab navigation

Supplementary files

Article information


Submitted
05 Sep 2019
Accepted
20 Dec 2019
First published
05 Feb 2020

This article is Open Access

Green Chem., 2020, Advance Article
Article type
Paper

A successful search for new, efficient, and silver-free manufacturing processes for key platinum(II) intermediates applied in antibody–drug conjugate (ADC) production

E. Merkul, N. J. Sijbrandi, I. Aydin, J. A. Muns, R. J. R. W. Peters, P. Laarhoven, H. Houthoff and G. A. M. S. van Dongen, Green Chem., 2020, Advance Article , DOI: 10.1039/C9GC03130H

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. Material from this article can be used in other publications provided that the correct acknowledgement is given with the reproduced material and it is not used for commercial purposes.

Reproduced material should be attributed as follows:

  • For reproduction of material from NJC:
    [Original citation] - Published by The Royal Society of Chemistry (RSC) on behalf of the Centre National de la Recherche Scientifique (CNRS) and the RSC.
  • For reproduction of material from PCCP:
    [Original citation] - Published by the PCCP Owner Societies.
  • For reproduction of material from PPS:
    [Original citation] - Published by The Royal Society of Chemistry (RSC) on behalf of the European Society for Photobiology, the European Photochemistry Association, and RSC.
  • For reproduction of material from all other RSC journals:
    [Original citation] - Published by The Royal Society of Chemistry.

Information about reproducing material from RSC articles with different licences is available on our Permission Requests page.


Social activity

Search articles by author

Spotlight

Advertisements